Amphastar Pharmaceuticals, Inc. (FRA:29A)

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals had revenue of $191.84M USD in the quarter ending September 30, 2025, with 0.33% growth. This brings the company's revenue in the last twelve months to $723.31M, down -0.03% year-over-year. In the year 2024, Amphastar Pharmaceuticals had annual revenue of $731.97M with 13.59% growth.

• Revenue (ttm): $723.31M
• Revenue Growth: -0.03%
• P/S Ratio: 1.78
• Revenue / Employee: $356.66K
• Employees: 2,028
• Market Cap: 1.10B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	731.97M	87.57M	13.59%
Dec 31, 2023	644.40M	145.41M	29.14%
Dec 31, 2022	498.99M	61.22M	13.98%
Dec 31, 2021	437.77M	87.92M	25.13%
Dec 31, 2020	349.85M	27.49M	8.53%
Dec 31, 2019	322.36M	27.69M	9.40%
Dec 31, 2018	294.67M	54.49M	22.69%
Dec 31, 2017	240.18M	-14.99M	-5.87%
Dec 31, 2016	255.17M	3.65M	1.45%
Dec 31, 2015	251.52M	41.06M	19.51%
Dec 31, 2014	210.46M	-19.22M	-8.37%
Dec 31, 2013	229.68M	25.36M	12.41%
Dec 31, 2012	204.32M	-	-